Publikation
Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)
Konferenzpapier/Poster - 28.09.2015
Siano Marco
Bereiche
Kontakt
Zitation
Siano M (2015). Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC).
Art
Konferenzpapier/Poster (Deutsch)
Name der Konferenz
ESMO 2015 (Wien)
Titel der Konferenzberichte
Eur J Cancer 2015;51(suppl 3);S576. abstract 2861.
Veröffentlichungsdatum
28.09.2015
Seiten
576
Verlag
Elsevier
Kurzbeschreibung/Zielsetzung
Siano M, Molinari F, Martin V et al. Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC). Eur J Cancer 2015;51(suppl 3);S576. abstract 2861.